603079.SS · 圣达生物
China A-shares · RS rating 54 · As of 2026-10-14
| Price | 12.67 CNY |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 63 / 85 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 12 / 20 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.6% |
| Distance from 52-week high | +42.4% |
| Market cap (USD) | $376.5M |